Economic Overview - Q4 US GDP growth was weaker than expected, with a quarterly annualized rate of +1.4%, down from +4.4% in the previous quarter and below the expected +2.5%[1] - Year-on-year GDP growth for Q4 was +2.2%, slightly down from +2.3% previously and below the expected +2.5%[1] Consumer Spending - Q4 private consumption increased at a quarterly annualized rate of +2.4%, down from +3.5% previously and below the expected +2.6%[3] - Service consumption remained the main driver, while durable goods consumption weakened, with a quarterly annualized rate of -0.9% for durable goods[3] Investment Trends - Q4 private investment rose at a quarterly annualized rate of +3.8%, compared to 0% in the previous quarter and above the expected +2.5%[3] - AI-related investments are projected to grow by +16% year-on-year in 2025, while residential investment is expected to decline by -2.2%[3] Government Spending - Q4 government spending fell significantly, with a quarterly annualized rate of -5.1%, down from +2.2% previously and below the expected -2.1%[3] - The decline in federal government spending was particularly sharp, with a quarterly annualized rate of -16.6%[3] Tax Refunds and Economic Stimulus - The OBBBA Act is expected to provide approximately $100 billion in tax refunds, potentially boosting consumer spending by 0.6 percentage points if fully utilized[4] - The act includes various tax relief measures aimed at increasing disposable income for households in 2026[4] Export and Import Dynamics - Net exports negatively impacted GDP growth, contributing -1.5% to the overall GDP growth rate in Q4[3] - Exports decreased at a quarterly annualized rate of -0.9%, while imports slowed to -1.3%[3]

1. Report Industry Investment Rating No information provided in the given content. 2. Core Views of the Report - In 2025, the number of newly - defaulted credit bond issuers and the scale of defaulted bonds decreased significantly. The default of state - owned enterprises came to an end, while the risks of broad - sense private enterprises continued to be exposed. The scale of default repayment increased, but most real - estate enterprises only paid interest without repaying the principal [1][6][7]. - The overall, non - state - owned marginal and cumulative default rates of credit bonds in 2025 decreased slightly. The net financing scale of non - state - owned enterprises turned positive for the first time since 2018. Industries such as electrical equipment, textile and clothing, real estate, and commercial trade had a cumulative default rate of over 5% [3][19][20]. - Looking forward to 2026, the policy bottom - line is to prevent systemic risks. The overall credit risk is relatively controllable, but the operating pressure of some tail - end entities in certain industries remains, and default risks are still worthy of attention [3][8]. 3. Summary According to the Directory 3.1 2025 Credit Bond Market Default Feature Summary - **Newly - defaulted issuers and bond scale**: The number of newly - defaulted credit bond issuers in 2025 decreased to 4, with 3 from the real - estate industry and its upstream and downstream chains. The scale of defaulted bonds continued to decline, and the extended - term part due to the continuous exposure of default risks from 2022 - 2023 ended by the end of 2024 [1][6]. - **Enterprise nature**: State - owned enterprise defaults ended in 2025, while the risks of broad - sense private enterprises continued to be exposed, especially those in the real - estate industry chain that had not defaulted during the previous strict regulatory period [7]. - **Default repayment**: In 2025, there were 118 cases of default bond repayments, with a total principal repayment of 14.3 billion yuan and interest of 639 million yuan. The real - estate industry repaid 12.1 billion yuan in principal, and 11 out of 17 real - estate enterprises only paid interest without repaying the principal [7]. 3.2 Default Analysis: Continuous Exposure of Broad - sense Private Enterprises and Slight Decline in Cumulative Default Rate 3.2.1 Default Overview - The number of newly - defaulted credit bond issuers decreased to 4 in 2025, all non - state - owned. The total outstanding bonds of defaulted issuers increased significantly year - on - year, mainly due to the extension of Vanke's large - scale bonds. The scale of defaulted bonds decreased by 67% year - on - year [11]. - Industry - wide, since 2014, credit bond default issuers have been widely distributed across 29 Shenwan industries, and in 2025, they were mainly in real estate, building decoration, and power equipment. Regionally, since 2014, default issuers have covered most provinces, and in 2025, they were in Guangdong and Zhejiang [14]. 3.2.2 Default Rate - The overall, non - state - owned marginal and cumulative default rates of credit bonds in 2025 decreased slightly. The non - state - owned net financing scale turned positive for the first time since 2018 to 24.3 billion yuan [19]. - Industries such as electrical equipment, textile and clothing, real estate, and commercial trade had a cumulative default rate of over 5%, with real estate and commercial trade having relatively high default scales, and electrical equipment and textile and clothing having relatively low total bond - issuing scales [20]. 3.2.3 Default Reasons - Macroeconomic policies and market environment continuously affected the credit risks of entities. Entities like Xinjie Holdings, Zhengxinglong Real Estate, and Vanke were greatly affected by the previous strict real - estate regulatory policies, while Shanshan Group's poor performance was due to industry cycle changes [3][25]. 3.3 Default Recovery Situation - The cumulative recovery rate and recovery time of defaulted credit bonds have been decreasing year by year. Since 2020, the annual default recovery rate has been less than 20%, and the average recovery time is within two years, with the decline narrowing in 2025 [30]. - As of 2025, the cumulative default recovery rate of state - owned enterprises was 25.12%, 13 percentage points higher than that of non - state - owned enterprises, and the gap remained basically the same as the previous year [33]. - In 2025, real - estate bond repayments still dominated. The total principal repayment of defaulted bonds was 14.3 billion yuan, with the real - estate industry repaying 12.1 billion yuan. Sunac repaid 9.5 billion yuan in principal, and Shanshan Group among the newly - defaulted issuers in 2025 repaid 267 million yuan in principal [37].

Investment Rating - The industry investment rating is "Recommended," indicating an expected increase in the industry index exceeding the benchmark index by more than 5% in the next 3-6 months [21]. Core Insights - The insurance sector's asset management balance reached approximately 38.5 trillion yuan by the end of Q4 2025, reflecting a year-to-date growth of 15.70% [2][4]. - The average comprehensive solvency adequacy ratio for insurance companies stands at 181.1%, with life insurance companies at 169.3% and property insurance companies at 243.5% [2]. - The industry is experiencing a shift in dividend insurance products, with a notable decrease in the preset interest rate to 1.25%, down from the previous cap of 1.75% [2]. - The overall premium income for the industry in 2025 is projected to be 6.12 trillion yuan, with a high fund conversion rate of 85% [4]. Summary by Sections Asset Management - As of Q4 2025, the asset management balance of insurance companies is nearly 38.5 trillion yuan, with life insurance companies holding 34.66 trillion yuan and property insurance companies 2.42 trillion yuan [2][4]. - The fund conversion rate for life insurance companies is exceptionally high at 108%, while property insurance companies have a much lower rate of 11% [4]. Equity Allocation - The allocation of equity and fund assets in the industry reached 5.70 trillion yuan, accounting for approximately 15.4% of total assets, maintaining a historical high [5]. - The stock assets alone amount to 3.73 trillion yuan, representing 10.1% of total assets, with a year-on-year increase of 2.5% [5]. Investment Recommendations - The report suggests that the insurance sector is currently in a correction phase, primarily influenced by liquidity conditions around the Spring Festival [5]. - The report recommends specific companies for investment, including China Pacific Insurance, China Life Insurance, and New China Life Insurance, with respective PEV valuations [6][10].

Investment Rating - The industry investment rating is "Recommended," indicating an expected increase in the industry index exceeding the benchmark index by more than 5% in the next 3-6 months [21]. Core Insights - The insurance sector's total asset allocation reached approximately 38.5 trillion yuan by the end of Q4 2025, reflecting a year-to-date growth of 15.7%, with a net increase of over 5 trillion yuan throughout the year [2][4]. - The average comprehensive solvency adequacy ratio for insurance companies stands at 181.1%, with life insurance companies at 169.3% and property insurance companies at 243.5% [2]. - The industry is experiencing a shift in dividend insurance products, with a notable decrease in the preset interest rate to 1.25%, down from the previous cap of 1.75% [2]. - The overall premium income for the industry in 2025 is projected to be 6.12 trillion yuan, with a high fund conversion rate of 85% [4]. Summary by Sections Market Performance - The insurance index decreased by 2.52%, underperforming the market by 2.88 percentage points, with significant variations in individual stock performances [1]. Asset Allocation - The allocation of equity and fund assets in the insurance sector reached 5.70 trillion yuan, accounting for approximately 15.4% of total assets, maintaining a historical high [5]. - The stock assets alone amounted to 3.73 trillion yuan, representing 10.1% of total assets, with a year-on-year increase of 2.5% [5]. Company Performance and Valuation - The estimated PEV (Price to Embedded Value) for major life insurance companies is as follows: China Life at 0.89x, New China Life at 0.85x, Ping An at 0.78x, and China Pacific at 0.69x [6]. - The recommended order for investment in major companies is China Pacific, Ping An, China Life H, and China Property Insurance [6]. Future Outlook - The report anticipates that dividend insurance will attract household savings during the interest rate decline cycle, supporting growth in new premium income and net profit value (NBV) for life insurance [5]. - The long-term interest rates are expected to stabilize and rise, which may positively influence the PEV towards 1x [5].

Investment Rating - The report gives a "Recommended" rating for the company, marking its first coverage [4][8]. Core Views - The company is a key player in China's large and medium-sized aircraft development and manufacturing, contributing significantly in three areas: military aircraft, domestic civil aircraft, and international cooperation [6][24]. - The report highlights the strategic importance of the Y-20 military transport aircraft, which fills a gap in domestic large military transport capabilities and has potential for further development and international market competitiveness [7][43]. - The domestic civil aircraft segment, particularly the C919 and C909, is expected to see substantial growth, supported by strong orders from major domestic airlines [9][24]. - The international subcontracting business is robust, with the company being a major supplier for Airbus and Boeing, ensuring a steady flow of orders and revenue [19][24]. Summary by Sections Company Overview - The company was established in 1997 and became the first listed company in China's aviation manufacturing sector. It focuses on the integrated development and manufacturing of large and medium-sized military and civil aircraft [12][15]. - Following a significant asset restructuring in 2020, the company has positioned itself as a specialized entity for large and medium-sized aircraft manufacturing [12][25]. Military Aircraft - The Y-20 strategic transport aircraft, independently developed by the company, is crucial for rapid troop deployment and logistics support, showcasing its capabilities in both military and humanitarian missions [33][34]. - The Y-20 serves as a platform for further developments, such as the Y-20B, which features enhanced capabilities with domestically produced engines [36][37]. Domestic Civil Aircraft - The company is the largest structural supplier for the C919 and C909 aircraft, which are expected to see significant market demand, with projections of thousands of new aircraft deliveries in the coming decades [9][24]. - The report emphasizes the potential of the domestic regional aircraft market, with the C909 expected to capture a significant share [9][24]. International Cooperation - The company is a major player in international subcontracting, producing components for Airbus and Boeing, which secures its business growth amid a backlog of orders from these manufacturers [19][24]. - The report notes that the company delivered 1,267 units in international subcontracting projects in 2024, indicating a strong operational capacity [21][24]. Financial Projections - The company is projected to achieve a net profit of 1.14 billion in 2025, with a compound annual growth rate of 11.7% from 2024 to 2027 [5][8]. - Earnings per share (EPS) are expected to grow from 0.37 in 2024 to 0.56 in 2027, reflecting the company's strong financial outlook [5][8].

Investment Rating - The report gives a "Recommended" rating for the company, marking its first coverage [4][8]. Core Insights - The company is a key player in China's large and medium aircraft development and manufacturing, contributing significantly in three areas: military aircraft, domestic civil aircraft, and international cooperation and subcontracting [6][24]. - The company has shown a revenue growth from 32.7 billion to 43.2 billion from 2021 to 2024, with a compound annual growth rate (CAGR) of 10% [4][25]. - The net profit attributable to shareholders is projected to grow from 1.023 billion in 2024 to 1.552 billion in 2027, with a CAGR of 16% [5][8]. Summary by Sections Company Overview - The company was established in 1997 and became the first listed company in China's aviation manufacturing sector. It focuses on the integrated development and manufacturing of large and medium aircraft [12][15]. - The company has undergone significant restructuring to focus on military and civil aircraft manufacturing, aiming to become a world-class innovative aviation enterprise [12][15]. Military Aircraft - The company independently developed the Y-20 military strategic transport aircraft, filling a gap in China's large military transport aircraft capabilities [4][33]. - The Y-20 serves as a platform for various applications, including air refueling and emergency rescue, enhancing its strategic importance [7][37]. Domestic Civil Aircraft - The company is a major supplier for the C919 and C909 aircraft, which are expected to see significant demand in the coming years, with projections of 7,250 single-aisle jets and 1,703 twin-aisle jets needed in the Chinese market from 2025 to 2044 [9][24]. - The company is also involved in the production of key components for the AG600 amphibious aircraft and the new regional aircraft, enhancing its position in the civil aviation market [19][24]. International Cooperation - The company is one of the largest participants in international subcontracting, producing components for Airbus and Boeing, which secures a steady flow of business [4][19]. - The backlog of orders for Boeing and Airbus exceeds 15,000 aircraft, ensuring future business development for the company [8][19]. Financial Projections - The company is expected to achieve net profits of 1.14 billion, 1.32 billion, and 1.55 billion from 2025 to 2027, with corresponding earnings per share (EPS) of 0.41, 0.47, and 0.56 [5][8]. - The price-to-earnings (PE) ratios are projected to decrease from 74 in 2025 to 54 in 2027, indicating potential growth in profitability [5][8].

Investment Rating - The report maintains a recommendation for the real estate industry [2] Core Views - The real estate market is experiencing a decline in new and second-hand housing transaction volumes, with new housing transaction area down by 28% year-on-year during the Spring Festival period [19][23] - The report highlights three main issues in the real estate market: a decline in new housing demand, unresolved inventory issues, and the negative impact of land finance on the economy [31] Summary by Sections Industry Basic Data - The total number of listed companies in the real estate sector is 107, with a total market capitalization of 12,627.81 billion and a circulating market capitalization of 12,094.33 billion [2] Relative Index Performance - The absolute performance of the real estate sector is 0.9% for one month, 3.7% for six months, and 5.7% for twelve months, while the relative performance is 3.0%, -7.9%, and -13.7% respectively [3] Sales Data - New housing transaction area in 20 cities decreased by 28% year-on-year during the Spring Festival, with a total transaction area of 181 million square meters [19] - Second-hand housing transaction area in 11 cities decreased by 22% year-on-year during the same period, with a total transaction area of 156 million square meters [23] Policy News - Local policies include a housing subsidy program in Quzhou, providing up to 80,000 yuan for families with multiple children, and new measures in Huizhou to enhance housing fund support and optimize credit policies [13][16] Company Dynamics - Longfor Group reported a contract sales amount of 24.5 billion yuan in January, with a total sales area of 300,000 square meters [17] - China Overseas Development acquired land in Hong Kong for 18.688 billion HKD, designated for residential use [18] - China Resources Land reported a total contract sales amount of approximately 116.5 billion yuan, with a year-on-year growth of 0.4% [18]

Investment Rating - The report maintains a recommendation for the real estate sector [2] Core Insights - The real estate market is experiencing a decline in new and second-hand housing transaction volumes, with new housing transaction area down by 28% year-on-year during the Spring Festival period [19][23] - The report highlights three main issues in the real estate market: a decline in new housing demand, unresolved inventory issues, and the negative impact of land finance on the economy [31] Industry Data - The total market capitalization of the real estate sector is approximately 1,262.78 billion [2] - The sector's performance over the past month shows an absolute increase of 0.9%, but a relative decrease of 3.0% compared to the benchmark [3] Sales Performance - New housing sales in 20 cities saw a year-on-year decrease of 28%, with a total transaction area of 181 million square meters during the Spring Festival [19] - Second-hand housing sales in 11 cities also decreased by 22%, with a total transaction area of 156 million square meters [23] Policy Developments - Local governments are implementing housing subsidy policies, such as in Quzhou, where families can receive up to 80,000 yuan in subsidies for purchasing new homes [13] - In Huizhou, new policies include increased housing fund loan limits and measures to enhance housing quality and market order [16] Company Dynamics - Longfor Group reported a contract sales amount of 2.45 billion yuan in January, with a total sales area of 300,000 square meters [17] - China Overseas Development acquired land in Hong Kong for 1.8688 billion HKD, designated for residential use [18] - Vanke's stock increased by 8.4%, while Shimao Group's stock decreased by 17.7% [11][15]

Group 1: Liquidity - The net outflow of leveraged funds reached a new high since April 1998, amounting to -737 billion CNY, placing it in the 1st percentile over the past three years[12] - The issuance of equity public funds rebounded to a historical high of 259 billion CNY, representing the 97th percentile[6] - The net outflow of stock ETFs increased to -488 billion CNY, which is in the 3rd percentile over the past three years[20] Group 2: Market Demand - Equity financing amounted to 206 billion CNY, placing it in the 83rd percentile over the past three years[26] - The net reduction in industrial capital reached -100.8 billion CNY, which is in the 83rd percentile over the past three years[29] - The net inflow of southbound funds decreased to 246 billion CNY, which is in the 77th percentile over the past three years[38] Group 3: Trading Congestion - The trading heat for the building materials sector increased by 19 percentage points to 68%, indicating strong market interest[55] - The trading heat for the liquor sector rose by 10 percentage points to 26%[50] - The trading heat for the medical services sector decreased by 18 percentage points to 58%[46] Group 4: Investor Sentiment - Retail investor net inflow decreased to 117.1 billion CNY, down by 447.4 billion CNY from the previous value, placing it in the 65.4th percentile over the past five years[2] - The search interest for A-shares on social media declined, reflecting a drop in trading sentiment ahead of the holiday[2]

Investment Rating - The report assigns a "Strong Buy" rating to the company for the first time [5][8]. Core Insights - The company has successfully commercialized its first product, the KRAS G12C inhibitor, and has established a partnership with AstraZeneca for its next-generation pan-KRAS inhibitor, JAB-23E73, which is expected to accelerate global value realization [5][6]. - The company is innovating in the ADC field with tADC and iADC platforms, which aim to overcome traditional treatment limitations and enhance therapeutic efficacy [5][6]. - The financial projections indicate significant revenue growth, with expected revenues of 234 million, 627 million, and 508 million CNY for 2025, 2026, and 2027, respectively, alongside a notable increase in net profit in 2026 [5][8]. Financial Summary - Total revenue (CNY million): 156 in 2024A, 234 in 2025E, 627 in 2026E, and 508 in 2027E, with year-on-year growth rates of 145.1%, 50.5%, 167.6%, and -19.1% respectively [5]. - Net profit attributable to shareholders (CNY million): -156 in 2024A, -15 in 2025E, 313 in 2026E, and 192 in 2027E, with year-on-year growth rates of 56.6%, 90.7%, 2,258.6%, and -38.6% respectively [5]. - Earnings per share (CNY): -0.20 in 2024A, -0.02 in 2025E, 0.40 in 2026E, and 0.24 in 2027E [5]. Market Position and Product Pipeline - The company has a comprehensive pipeline focusing on KRAS and other challenging drug targets, with its first commercial product already contributing to cash flow [6][33]. - The partnership with AstraZeneca for JAB-23E73 is expected to enhance the company's competitive edge in the oncology sector [7][33]. - The company is advancing multiple ADC candidates, including tADC and iADC, which are anticipated to address unmet medical needs in cancer treatment [5][6].